Kinvard Bio is a biotech startup launched by Kineticos Life Sciences to combat antimicrobial resistance.
Kinvard Bio has raised $2.7M in total funding. The most recent round was Grant. The last funding was announced in July 2025.
Kinvard Bio's investors include CARB-X, Kineticos Life Sciences.
Kinvard Bio is headquartered in Raleigh, United States.
Kinvard Bio is a biotech startup launched by Kineticos Life Sciences to combat antimicrobial resistance.
Kinvard Bio is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Kinvard Bio — Funding & Investors." VCBacked, July 29, 2025, https://www.vcbacked.co/company/kinvard-bio. Accessed November 15, 2026.
VCBacked. (2025). Kinvard Bio — Funding & Investors. Retrieved November 15, 2026, from https://www.vcbacked.co/company/kinvard-bio
{{cite web |title=Kinvard Bio — Funding & Investors |url=https://www.vcbacked.co/company/kinvard-bio |website=VCBacked |access-date=November 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Kinvard Bio? Request a listing update